Patheon expands reach of soft-gel caps; Almac boasts of successful MHRA inspections;

> Patheon has teamed with PROCAPS in Columbia to provide P-Gels soft-gel capsulation manufacturing services worldwide. Release

> Almac's sciences business unit is boasting successful MHRA inspections at its Craigavon, Ireland HQ plant and Elvingston, Scotland sites. Release

> CMO Pharmaceutics International has begun construction of a 24,000-square-foot GMP aseptic fill/finish manufacturing facility at its Hunt Valley, MD, campus. Release

> Frost & Sullivan anticipates more than a doubling of contract manufacturing revenue in Europe, to $20.8 billion in 2018. Announcement

> Massachusetts biotechs are targeting the biosimilars market. Story

> India has extended its January deadline for secondary-packaging barcoding on drug exports to this coming July; the primary-packaging deadline was pushed to January 2013. Story

> Generics giant Teva ($TEVA) has "rationalized" logistics with a custom plastic pallet from Dolav.  Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.